
Altamira Therapeutics Ltd. Common Shares 0.01 SF (Bermuda)
CYTO
CYTO: Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders. Its product Bentrio is a drug-free nasal spray for personal protection against airborne viruses and allergens.
moreShow CYTO Financials
Recent trades of CYTO by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CYTO's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on CYTO's company Twitter account
Number of mentions of CYTO in WallStreetBets Daily Discussion
Recent insights relating to CYTO
Recent picks made for CYTO stock on CNBC
ETFs with the largest estimated holdings in CYTO
Flights by private jets registered to CYTO